Chemours Files 2024 Proxy Statement

TL;DR

Chemours proxy out - vote on exec pay & board.

AI Summary

The Chemours Company filed its DEF 14A proxy statement on April 11, 2024, for its annual meeting on May 21, 2024. This filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include director elections and executive pay packages.

Why It Matters

This filing provides shareholders with crucial information to make informed voting decisions on company leadership and policies, impacting the company's strategic direction and financial accountability.

Risk Assessment

Risk Level: medium — Proxy statements can reveal details about executive compensation, potential shareholder activism, or significant corporate governance changes that may impact stock price.

Key Numbers

• 1934 Act — SEC Act (Governing legislation for the filing)

Key Players & Entities

• The Chemours Company (company) — Filer of the DEF 14A
• 1007 Market Street, Wilmington, DE 19801 (address) — Company's business and mail address
• 20240411 (date) — Filing date of the DEF 14A
• 20240521 (date) — Annual meeting date

FAQ

From the Filing

0001104659-24-046287.txt : 20240411 0001104659-24-046287.hdr.sgml : 20240411 20240411160611 ACCESSION NUMBER: 0001104659-24-046287 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 57 CONFORMED PERIOD OF REPORT: 20240521 FILED AS OF DATE: 20240411 DATE AS OF CHANGE: 20240411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 24838549 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 DEF 14A 1 tm242636-d3_def14a.htm DEF 14A tm242636-1_nonfiling - none - 29.2758622s TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant   ☒ Filed by a Party other than the Registrant    ☐ ​ ​ Check the appropriate box: ​ ​ ​ ​ ☐ ​ ​ ​ Preliminary Proxy Statement ​ ​ ​ ​ ☐ ​ ​ ​ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ​ ​ ​ ​ ☒ ​ ​ ​ Definitive Proxy Statement ​ ​ ​ ​ ☐ ​ ​ ​ Definitive Additional Materials ​ ​ ​ ​ ☐ ​ ​ ​ Soliciting Material under §240.14a-12 ​ ​ THE CHEMOURS COMPANY ​ (Name of Registrant as Specified in its Charter) ​ (Name of Person(s) Filing Proxy Statement, if other than the Registrant) ​ ​ Payment of Filing Fee (Check the appropriate box): ​ ​ ​ ​ ☒ ​ ​ ​ No fee required. ​ ​ ​ ​ ☐ ​ ​ ​ Fee paid previously with preliminary materials. ​ ​ ​ ​ ☐ ​ ​ ​ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 ​ ​ TABLE OF CONTENTS    TABLE OF CONTENTS ​ ​ ​ 1007 Market Street Wilmington, Delaware 19801 ​ April 11, 2024 Dear Fellow Shareholders: Thank you for your continued investment in Chemours. The Board of Directors recognizes the commitment and support of our key stakeholders, including our many long-term shareholders, and does not take this for granted. Following a period that presented both challenges, and important Board actions and management transitions, the Board is highly focused on engagement and transparency and earning the continued support of our stakeholders. The Board is confident in the future of our business and committed to ensuring our business is run in a manner that will enable Chemours to reach its full potential. As described in more detail in the summary section of this proxy statement, the Board has taken decisive actions in response to an internal review led by the Audit Committee with the assistance of independent outside counsel. These actions included swiftly announcing leadership changes after placing three members of senior management on administrative leave in late February. On March 22, 2024, the Board appointed Denise Dignam as President and Chief Executive Officer. As a long-tenured senior executive, Denise has been instrumental to Chemours and has led both our Titanium Technologies and Advanced Performance Materials businesses,